It's easy to get frustrated at the first couple of doctors. It's similarly easy to get frustrated at the first couple of small biotechs trying to find their place on the sun. At some point the problem begins to look systemic.
How do most/all major (or potentially major) drugs get across to most/all providers?
Our healthcare system needs better outreach and regulatory oversight. Better = less capture. Whose board would a former FDA commissioner rather sit on, Amarin's or a BP's?
I had my own “happy experience” with doctors last night. I gave a 1 hour presentation to a group of healthcare professionals from a small care facility (4 doctors, a couple nurses and pharmacists). HLS allowed me to make my own presentation (wish I had asked the Capt to polish my slides in advance) so I wasn’t confined to “on label” topics. Great feedback from all who attended. All 4 docs said they were impressed with the data and would begin prescribing it to their Pts. It generated enough interest that the local cardiologist is going to give an accredited (docs get CME credits) presentation in early April where all local docs will be invited. I have been asked to be his “warmup act” so I will get 10-15 minutes to talk “off label/off script” before his presentation.
Absolute truth: my presentation came with a 40 page full colour handout (different from the 42 slide presentation)
Of note: HLS has been super helpful and supportive. I haven’t seen or heard anything from Pfizer. Zero promotion/education/funding. Nothing
I remember the pain you mentioned. My cardio guy was a "Lovaza is known and just as good" Dr. He had heard of Vascepa, but did not give it any more weight, even though I pointed out the LDL comparison between the 2. I finally got a GREAT referral to a Dr. in my area and it's been Brand Vascepa since then (years ago).
Market Data 
Markets 
AI
